Genetic information and genetic discrimination how medical records vitiate legal protection

Abstract

This study compares currently enacted and pending legislation and policies concerning genetic information and genetic discrimination in Europe and the USA. The emergence of a multi-disciplinary scientific field comprising genetically-related areas and the discovery of new genetic factors have improved our ability to predict genetic risks associated with illness. Early detection and preventive healthcare thus hold promise for improving public health, but much remains unknown about the actual risks deriving from genetic testing. Positive (not-normal) test results may give little certainty of the actual severity of a disease. Genetic information could thus be used for social stigmatization and genetic discrimination. Western laws have been enacted in a context of unknown potential risks and benefits, and an increased number of regulatory initiatives is to be expected. Yet, there is currently no comprehensive US or European legal approach concerning genetic information and genetic discrimination and, despite legislation thus far enacted, the protection of individuals remains uncertain, and this could have a negative impact on attitudes to genetic testing, with important consequences for public health strategies to prevent disease.

Keywords

genetic discrimination genetic information international legislation regulatory trends.

Get full access to this article

View all access options for this article.

References

Kennet W. Parliaments and screening; ethical and social problems arising from testing and screening for HIV and genetic disease. London : John Libbey CIC Eurotext, ISBN: 274200095X, 1995: 153-4.

Masood E. UK insurers oppose moratorium plea on use of genetic data. Nature 1998; 391: 3.

Hudson KL , Rothenberg KH , Andrews LB , Kahn MJ , Collins FS Genetic discrimination and health insurance: an urgent need for reform . Science 1995; 270: 391-3.

US Government. HIPAA. Pub. L. 1996: 104-9.

Genetic information and health insurance. Report of the task force on genetic information and insurance. NIH/DOE Working Group on Ethical, Legal, and Social Implications of Human Genome Research. Hum Gene Ther 1993; 4: 789-808.

US Department of Labour , Department of Health and Human Services, Equal Employment Opportunity Commission and the Department of Justice. Genetic information and the work-place. Bethesda MA. National Human Genome Research Institute, 1998, Jan. 20.

Wadman M. New Jersey outlaws genetic discrimination. Nature 1996; 384: 202.

Gore A. Call for legislation to ban genetic discrimination. Bethesda, MA: National Human Genome Research Institute , 1998, Jan. 20.

Sandberg P. Genetic information and life insurance: a proposal for an ethical European policy. Soc Sci Med 1995; 40: 1549-59.

10.

Perman E. Försäkringsmedicin-Prognosmedicin. Läkartidningen 1996; 3: 93:56-8.

11.

Rothenburg KH Genetic information and health insurance: State legislative approaches. J Law Med Ethics 1995; 23: 312-9.

12.

Pokorski RJ Insurance underwriting in the genetic era . Am J Hum Genet 1997; 60: 205-16.

13.

Holzman NA Benefits and risks of emerging genetic technologies: the need for regulation . Clin Chem 1994; 40: 1652-7.

14.

New bills seek to prevent misuse of medical data. Nat Biotechnol 1997; 15: 398.

15.

Bratt O. , Kristoffersson U. , Lundgren R. , Olsson H. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 1997; 50: 360-5.